Others

Syncom Healthcare Ltd - Outcome Of Board Meeting Held On 30Th May 2019 In Terms Of Regulations 30 Of SEBI (Listing Obligation And Disclosure Requirement),2015

| Updated on May 31, 2019

The Board of Directors of the Company in their meeting held today, i.e. Wednesday, 30th May, 2019 (commenced at 03:30 P. M. & concluded at 05:10 PM), have considered and approved inter-alia, the following business(s):

1. The Audited Standalone Financial Results and the Audit Report on Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the quarter and year ended 31st March, 2019.

2. Declaration of unmodified opinion on Auditors Report on annual financial results for the quarter and year ended 31st March, 2019.

3. Appointment of Dr. Bhishampal Singh Yadav as Additional Director of the Company. His brief profile is as follows:

Dr. Bhishampal Singh Yadav is a post graduate in science, B.ED and PHD in Botany. He has over two decade of experience in the field of Herbal pharma, research & development. His rich experience in corporate world will benefit the Company as a whole and we look forward for his guidance and support in the production and management.

Pdf Link: Syncom Healthcare Ltd - Outcome Of Board Meeting Held On 30Th May 2019 In Terms Of Regulations 30 Of SEBI (Listing Obligation And Disclosure Requirement),2015

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 31, 2019
This article is closed for comments.
Please Email the Editor